Side Effects of Anticoagulant and Antithrombotic Therapy and their Management
The risk of thromboembolic event increases in patients who discontinue antithrombotic therapy, and there is no need to discontinue nonsteroidal anti- inflammatory drugs (NSAIDs), including low dose aspirin prior to interventional procedures. In contrast low-molecular-weight heparin (LMWH) or unfraction- ated heparin can be discontinued 12 hours prior to interventional procedures. Warfarin should be discon- tihued and international normalized ratio (INR) should be normalized to 1.4 or less for high risk procedures and 2 or less for low risk procedures. Necessity of dis- continuation of platelet aggregation inhibitors depends on the patient's condition, the planned procedure, risk factors, and the cardiologist's opinion.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Masui. The Japanese journal of anesthesiology - 65(2016), 7 vom: 23. Aug., Seite 724-733 |
| Sprache: |
Japanisch |
|---|
| Beteiligte Personen: |
Sugimoto, Koichi [VerfasserIn] |
|---|
| Themen: |
5Q7ZVV76EI |
|---|
| Anmerkungen: |
Date Completed 11.12.2018 Date Revised 11.12.2018 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM289924758 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM289924758 | ||
| 003 | DE-627 | ||
| 005 | 20231225063621.0 | ||
| 007 | tu | ||
| 008 | 231225s2016 xx ||||| 00| ||jpn c | ||
| 028 | 5 | 2 | |a pubmed24n0966.xml |
| 035 | |a (DE-627)NLM289924758 | ||
| 035 | |a (NLM)30358304 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a jpn | ||
| 100 | 1 | |a Sugimoto, Koichi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Side Effects of Anticoagulant and Antithrombotic Therapy and their Management |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 11.12.2018 | ||
| 500 | |a Date Revised 11.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The risk of thromboembolic event increases in patients who discontinue antithrombotic therapy, and there is no need to discontinue nonsteroidal anti- inflammatory drugs (NSAIDs), including low dose aspirin prior to interventional procedures. In contrast low-molecular-weight heparin (LMWH) or unfraction- ated heparin can be discontinued 12 hours prior to interventional procedures. Warfarin should be discon- tihued and international normalized ratio (INR) should be normalized to 1.4 or less for high risk procedures and 2 or less for low risk procedures. Necessity of dis- continuation of platelet aggregation inhibitors depends on the patient's condition, the planned procedure, risk factors, and the cardiologist's opinion | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
| 650 | 7 | |a Platelet Aggregation Inhibitors |2 NLM | |
| 650 | 7 | |a Warfarin |2 NLM | |
| 650 | 7 | |a 5Q7ZVV76EI |2 NLM | |
| 650 | 7 | |a Heparin |2 NLM | |
| 650 | 7 | |a 9005-49-6 |2 NLM | |
| 650 | 7 | |a Aspirin |2 NLM | |
| 650 | 7 | |a R16CO5Y76E |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Masui. The Japanese journal of anesthesiology |d 1965 |g 65(2016), 7 vom: 23. Aug., Seite 724-733 |w (DE-627)NLM000062391 |x 0021-4892 |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2016 |g number:7 |g day:23 |g month:08 |g pages:724-733 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2016 |e 7 |b 23 |c 08 |h 724-733 | ||